Skip to content

Ibogaine: all studies

Page 16 of 62: studies 151 to 160 of 613, newest first. Back to the ibogaine overview

Research

Effects of ibogaine per os application on redox homeostasis in rat liver and erythrocytes

Archives of Biological Sciences December 5, 2018 Teodora Vidonja Uzelac, Nikola Tatalović, Milica Mijović et al. 7 citations

Ibogaine, administered as a single oral dose (1-25 mg/kg body weight), has been used as an addiction-interrupting agent. Its effects persist for up to 72 h. Ex vivo results showed that ibogaine induced cellular energy consumption and restitution, followed by increased reactive oxygen species production and antioxidant activity. Therefore, the aim of this work was to explore the effect of a...

DOI: 10.2298/abs180918055v (opens in new tab) Oxidative stress Pharmacology Superoxide dismutase Glutathione peroxidase +8

Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence.

Journal of Clinical Psychopharmacology December 1, 2018 Thomas Knuijver, Maarten Belgers, Wiebren Markus et al.

expressed in brain regions associated with emotional processing. Modulation of the hypothalamic-pituitary-adrenal axis by altering cortisol tone also seems to be involved in this effect. The ECS modulates stress and anxiety. Serum AEA and 2-AG levels are increased after stress, and AEA levels are negatively associated to baseline anxiety and are significantly reduced in womenwith major...

Ibogaine Modifies GDNF, BDNF and NGF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits

ChemRxiv October 29, 2018 Soledad Marton, Bruno González, Sebastián Rodríguez et al. preprint

Ibogaine is a psychedelic alkaloid which has been subject of intense scientific research due to its reported ability to attenuate drug-seeking behavior. Recent work suggested that ibogaine effects on alcohol self-administration in rats was related to the release of Glial Cell Derived Neurotrophic Factor (GDNF) in the Ventral Tegmental Area (VTA), a mesencephalic region which hosts soma of...

DOI: 10.26434/chemrxiv.7261559 (opens in new tab) Ventral tegmental area Neurotrophic factors Dopaminergic Nucleus accumbens +5

Phytochemical characterization of Tabernanthe iboga root bark and its effects on dysfunctional metabolism and cognitive performance in high-fat-fed C57BL/6J mice

Journal of Food Bioactives September 30, 2018 Bayissi Bading-Taïka, Tunde Akinyeke, Armando Alcazar Magana et al. 14 citations

Preparations of the root bark of Tabernanthe iboga have long been used in Central and West African traditional medicine to combat fatigue, as a neuro-stimulant in rituals, and for treatment of diabetes. The principal alkaloid of T. iboga, ibogaine, has attracted attention in many countries around the world for providing relief for opioid craving in drug addicts. Using a plant metabolomics...

DOI: 10.31665/jfb.2018.3154 (opens in new tab) Full text (opens in new tab) Phytochemical Bark sound Traditional medicine Pharmacology

Bwiti, iboga, trance and healing in Gabon

Mental Health, Religion & Culture September 14, 2018 Pierre Didier Nyongo Ndoua, Kaveh Vaghar

ABSTRACT The Bwiti is one out of several religions in Africa and through it, it is believed, that the members can be connected to the world of the ancestors. There is also the ritual of healing in Bwiti. In this ritual, participants are invited to take iboga. They fall into a trance and after this phase, which in principle lasts three days; those who were sick recover the health in many cases....

DARK Classics in Chemical Neuroscience: Ibogaine

ACS Chemical Neuroscience September 14, 2018 Michael Wasko, Paula A. Witt‐enderby, Christopher K. Surratt 63 citations

The West African iboga plant has been used for centuries by the Bwiti and Mbiri tribes to induce hallucinations during religious ceremonies. Ibogaine, the principal alkaloid responsible for iboga's psychedelic properties, was isolated and sold as an antidepressant in France for decades before its adverse effects precipitated its removal from the market. An ibogaine resurgence in the 1960s was...

DOI: 10.1021/acschemneuro.8b00294 (opens in new tab) Hallucinogen Nicotine Synthetic cannabinoids Nicotinic acetylcholine receptor +2

Ibogaine: History, Pharmacology, Spirituality, & Clinical Data

Integrative Addiction and Recovery September 1, 2018 Benjamin Shapiro 1 citation

Abstract Ibogaine is an indole alkaloid derived from the African shrub Tabernathe iboga with broad anti-addictive, anti-depressant, and central nervous system stimulating effects. It is categorized as an oneriogen (or atypical hallucinogen) and has been used in West African tribal rituals for centuries. It was identified by French explorers in the early 1900s, came to the United States in the...

Cardiac arrest after ibogaine intoxication.

Journal of arrhythmia August 1, 2018 Christian Steinberg, Marc W Deyell 18 citations

Ibogaine is a psychoactive herbal medication with alleged antiaddiction properties. We report a case of ibogaine intoxication mimicking Long-QT syndrome resulting in ventricular flutter and nearby cardiac arrest. A 61-year-old man experienced massive QT prolongation and ventricular flutter at a rate of 270 beats per minute requiring defibrillation after ingestion of a large dose of Ibogaine....

DOI: 10.1002/joa3.12061 (opens in new tab) Full text (opens in new tab) Delayed qt recovery Drug‐induced qt prolongation Long‐qt Ventricular arrhythmia +7

Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga

Journal of Biological Chemistry July 20, 2018 Scott C. Farrow, Mohamed O. Kamileen, Jessica Meades et al. 55 citations

Monoterpenoid indole alkaloids are a large (∼3000 members) and structurally diverse class of metabolites restricted to a limited number of plant families in the order Gentianales. Tabernanthe iboga or iboga (Apocynaceae) is native to western equatorial Africa and has been used in traditional medicine for centuries. Howard Lotsof is credited with bringing iboga to the attention of Western...

DOI: 10.1074/jbc.ra118.004060 (opens in new tab) Full text (opens in new tab) Indole alkaloid Apocynaceae Pharmacology Biochemistry +4

A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders

Journal of Psychedelic Studies June 1, 2018 Thaddeus James Camlin, Donald Eulert, A. Thomas Horvath et al. 21 citations

This study examined the lived experience of individuals who underwent ibogaine treatment for an opioid use disorder. Semi-structured interview questions probed for potential changes in predetermined categories derived from a literature review. Participants' experiences with ibogaine were analyzed for commonalities and emergent themes. Categories that emerged revealed themes about subjective...